Categories AlphaGraphs, Earnings, Technology
Broadcom delivers mixed Q2 results; slashes FY19 revenue outlook
Broadcom (Nasdaq: AVGO) surpassed Q2 earnings estimates, while it missed on revenue targets. Shares of Broadcom slumped about 7% in the after-hours as the company cut down its revenue outlook for FY19. The company reported non-GAAP earnings of $5.21 per share on revenue of $5.52 billion for the second quarter of 2019. Analysts had expected the semiconductor maker to earn $5.18 per share on revenue of $5.69 billion.
On a GAAP basis, the San Jose, California-based firm reported earnings of $1.64 per share compared to earnings of $8.33 per share in the prior-year quarter.
For the fiscal year 2019, Broadcom cut down its revenue outlook to $22.5 billion from the prior outlook of $24.5 billion.
“We currently see a broad-based slowdown in the demand environment, which we believe is driven by continued geopolitical uncertainties, as well as the effects of export restrictions on one of our largest customers. As a result, our customers are actively reducing their inventory levels, and we are taking a conservative stance for the rest of the year,” said CEO Hock Tan.
Also Read: Global semiconductor revenues to fall this year on supply glut, China weakness
Among the peers, Analog Devices (ADI) last month reported lower earnings and revenues for its most recent quarter, hurt by muted demand in the consumer and industrial segments. Earnings decreased year-over-year to $1.36 per share on revenues of $1.53 billion. Earlier, Intel (INTC) posted flat revenues and higher earnings for the first quarter. Revenues matched the market estimates, while earnings beat.
Broadcom stock, which ended up 0.67% at $281.61 today, had advanced 11% since the beginning of 2019 and 7% in the past 52 weeks.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on